Work

Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma

Year: 2020

Type: article

Study design: Observational Study

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2020.07.004

Authors: Luwei Tao, Ruoyu Miao, Tarek Mekhail, Jingxin Sun, Lingbin Meng, Cheng Fang, Jian Guan, Akriti Jain, Yuan Du, Amanda Allen, Brenda L. Rzeszutko, Mark A. Socinski, Chung-Che Chang

Institutions: AdventHealth Orlando, AdventHealth

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb

OpenAlex ID: W3042331645

FWCI: 2.39

Cites: 27

Cited by: 24

Related to: 10